BLFS
BioLife Solutions Inc.
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Best Electromedical Stocks 2026 →
BioLife Solutions (BLFS) Stock: Buy, Sell, or Hold?
$38.61
+1.31 (+3.51%)
â˛
5d:
-1.38%
30d:
+8.67%
90d:
+38.24%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 05, 2026
0d
Protect BLFS Gains
Updated Oct 5, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (44%)
Quality Score
48/100
Position
FAIR
Forward P/E & Valuation
117.0x
FAIR
vs 108.6x historical avg
Wall Street Target
$31.29
-19.0% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$36.70 / $39.76
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: BLFS is fairly priced but lacks strong directional signals. At 2.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Get Alerted When BLFS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.07
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$9.98
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLFS is currently trading at $38.61, which is considered fair based on recent price action. The stock's valuation (Forward PE: 117.0) is in line with its historical norms (108.6). At these levels, the market is pricing in 2.5% annual earnings growth.
Technical Outlook: Technically, BLFS is in a strong uptrend. The price is approaching resistance at $39.76. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: BLFS scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLFS is in a strong uptrend. The price is approaching resistance at $39.76. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: BLFS scores 31/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
48/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
43.8%
Trading Range & Key Levels
Support Level
$36.70
Resistance Level
$39.76
Current Trend
Strong Uptrend
Technical data as of
Oct 5, 2026
Protect Your Profits
Holding BLFS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (31/100)
- BULLISH: Strong upward momentum (+3.5%)
- BEARISH: Trading 19.0% above Wall St target ($31.29)
- BULLISH: Expecting earnings turnaround to 2.5% growth with 21.5% revenue growth
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
117.00
Wall Street Target
$31.29
(-19.0%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
-13.9%
Profit Margin
54.4%
Valuation Premium vs History
+2.5% premium
PE vs Historical
117.0 vs 108.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.5%
(market-implied from PE analysis)
1-Year Target
$39.58
(+3%)
2-Year Target
$40.56
(+5%)
3-Year Target
$41.58
(+8%)
3-Yr Target (if PE normalizes)
(PE: 117â109)
PE COMPRESSION
$38.59
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 117.0, Growth: 32.0%)
$88.80
(+130%)
Base:
(SPY PE: 19.7, Growth: 32.0%)
$14.95
(-61%)
Bear:
(PE: 16.7, Growth: 32.0%)
$12.71
(-67%)
Share BLFS Analysis
Share this live BLFS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BLFS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 28, 2026
Daily AI digest
AI Retail Discussion Summary:
Repligen reported Q2 revenue growth and raised full-year 2026 guidance, boosted by strong order momentum and the acquisition of BioLife Solutions.
Key Retail Themes:
Revenue growth
Acquisition of BioLife Solutions
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:10 PM ET
Data refreshes hourly during market hours. Next update: 9:10 PM
Data refreshes hourly during market hours. Next update: 9:10 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLFS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$486 | 40 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$82 | 44 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
21 analysts |
$203 | 49 HOLD |
|
WST
West Pharmaceutical ServâĻ |
STRONG BUY
16 analysts |
$471 | 50 HOLD |
|
RMD
ResMed Inc |
HOLD
20 analysts |
$264 | 58 HOLD |
Advanced BLFS Option Strategies
Professional options setups generated by AI based on today's BLFS price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BLFS Research Pages
